These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29487403)

  • 1. Use of an Alzheimer's disease polygenic risk score to identify mild cognitive impairment in adults in their 50s.
    Logue MW; Panizzon MS; Elman JA; Gillespie NA; Hatton SN; Gustavson DE; Andreassen OA; Dale AM; Franz CE; Lyons MJ; Neale MC; Reynolds CA; Tu X; Kremen WS
    Mol Psychiatry; 2019 Mar; 24(3):421-430. PubMed ID: 29487403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictability of polygenic risk score for progression to dementia and its interaction with APOE ε4 in mild cognitive impairment.
    Pyun JM; Park YH; Lee KJ; Kim S; Saykin AJ; Nho K;
    Transl Neurodegener; 2021 Aug; 10(1):32. PubMed ID: 34465370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia.
    Roberts RO; Christianson TJ; Kremers WK; Mielke MM; Machulda MM; Vassilaki M; Alhurani RE; Geda YE; Knopman DS; Petersen RC
    JAMA Neurol; 2016 Jan; 73(1):93-101. PubMed ID: 26569387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Language Differences Among Individuals with Normal Cognition, Amnestic and Non-Amnestic MCI, and Alzheimer's Disease.
    Liampas I; Folia V; Morfakidou R; Siokas V; Yannakoulia M; Sakka P; Scarmeas N; Hadjigeorgiou G; Dardiotis E; Kosmidis MH
    Arch Clin Neuropsychol; 2023 May; 38(4):525-536. PubMed ID: 36244060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.
    Kida J; Nemoto K; Ikejima C; Bun S; Kakuma T; Mizukami K; Asada T
    J Alzheimers Dis; 2016; 51(2):405-15. PubMed ID: 26890740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The validity of amnestic MCI and non-amnestic MCI at age 75 in the prediction of Alzheimer's dementia and vascular dementia.
    Jungwirth S; Zehetmayer S; Hinterberger M; Tragl KH; Fischer P
    Int Psychogeriatr; 2012 Jun; 24(6):959-66. PubMed ID: 22300486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olfactory identification in amnestic and non-amnestic mild cognitive impairment and its neuropsychological correlates.
    Vyhnalek M; Magerova H; Andel R; Nikolai T; Kadlecova A; Laczo J; Hort J
    J Neurol Sci; 2015 Feb; 349(1-2):179-84. PubMed ID: 25614440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degree of cognitive impairment does not signify early versus late mild cognitive impairment: confirmation based on Alzheimer's disease polygenic risk.
    Elman JA; Vuoksimaa E; Franz CE; Kremen WS;
    Neurobiol Aging; 2020 Oct; 94():149-153. PubMed ID: 32623261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validating the role of the Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) and a genetic risk score in progression to cognitive impairment in a population-based cohort of older adults followed for 12 years.
    Andrews SJ; Eramudugolla R; Velez JI; Cherbuin N; Easteal S; Anstey KJ
    Alzheimers Res Ther; 2017 Mar; 9(1):16. PubMed ID: 28259165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of progression to Alzheimer's disease for different neuropsychological Mild Cognitive Impairment subtypes: A hierarchical meta-analysis of longitudinal studies.
    Oltra-Cucarella J; Ferrer-Cascales R; Alegret M; Gasparini R; Díaz-Ortiz LM; Ríos R; Martínez-Nogueras ÁL; Onandia I; Pérez-Vicente JA; Cabello-Rodríguez L; Sánchez-SanSegundo M
    Psychol Aging; 2018 Nov; 33(7):1007-1021. PubMed ID: 30284855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Polygenic Risk Score and the Progression from Mild Cognitive Impairment to Alzheimer's Disease.
    Liu H; Lutz M; Luo S;
    J Alzheimers Dis; 2021; 84(3):1323-1335. PubMed ID: 34657885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Data-driven classification of cognitively normal and mild cognitive impairment subtypes predicts progression in the NACC dataset.
    Edmonds EC; Thomas KR; Rapcsak SZ; Lindemer SL; Delano-Wood L; Salmon DP; Bondi MW
    Alzheimers Dement; 2024 May; 20(5):3442-3454. PubMed ID: 38574399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early identification and heritability of mild cognitive impairment.
    Kremen WS; Jak AJ; Panizzon MS; Spoon KM; Franz CE; Thompson WK; Jacobson KC; Vasilopoulos T; Vuoksimaa E; Xian H; Toomey R; Lyons MJ
    Int J Epidemiol; 2014 Apr; 43(2):600-10. PubMed ID: 24370560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A polygenic risk score for Alzheimer's disease constructed using APOE-region variants has stronger association than APOE alleles with mild cognitive impairment in Hispanic/Latino adults in the U.S.
    Sofer T; Kurniansyah N; Granot-Hershkovitz E; Goodman MO; Tarraf W; Broce I; Lipton RB; Daviglus M; Lamar M; Wassertheil-Smoller S; Cai J; DeCarli CS; Gonzalez HM; Fornage M
    Alzheimers Res Ther; 2023 Aug; 15(1):146. PubMed ID: 37649099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High plasma homocysteine levels predict the progression from mild cognitive impairment to dementia.
    Zuliani G; Brombo G; Polastri M; Romagnoli T; Mola G; Riccetti R; Seripa D; Trentini A; Cervellati C
    Neurochem Int; 2024 Jul; 177():105763. PubMed ID: 38723899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E genotypes and plasma levels in mild cognitive impairment conversion to Alzheimer's disease: A follow-up study.
    Scarabino D; Broggio E; Gambina G; Maida C; Gaudio MR; Corbo RM
    Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1131-1138. PubMed ID: 27604972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of diabetes with amnestic and nonamnestic mild cognitive impairment.
    Roberts RO; Knopman DS; Geda YE; Cha RH; Pankratz VS; Baertlein L; Boeve BF; Tangalos EG; Ivnik RJ; Mielke MM; Petersen RC
    Alzheimers Dement; 2014 Jan; 10(1):18-26. PubMed ID: 23562428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI.
    Vos SJ; van Rossum IA; Verhey F; Knol DL; Soininen H; Wahlund LO; Hampel H; Tsolaki M; Minthon L; Frisoni GB; Froelich L; Nobili F; van der Flier W; Blennow K; Wolz R; Scheltens P; Visser PJ
    Neurology; 2013 Mar; 80(12):1124-32. PubMed ID: 23446677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of hippocampal volume and serum brain-derived neurotrophic factor as potential diagnostic markers of conversion from amnestic mild cognitive impairment to Alzheimer disease: A STROBE-compliant article.
    Fang Y; Du N; Xing L; Duo Y; Zheng L
    Medicine (Baltimore); 2019 Jul; 98(30):e16604. PubMed ID: 31348306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of Microvascular Dysfunction with Mild Cognitive Impairment and Cognitive Function Among Rural-Dwelling Older Adults in China.
    Jiang C; Wang Y; Dong Y; Liu R; Song L; Wang S; Xu Z; Niu S; Ren Y; Han X; Zhao M; Wang J; Li X; Cong L; Hou T; Zhang Q; Du Y; Qiu C
    J Alzheimers Dis; 2023; 93(3):1111-1124. PubMed ID: 37182877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.